The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Pipa-Muniz, M
- Castells, L
- Pascual, S
- Fernandez-Castroagudin, J
- Diez-Miranda, I
- Irurzun, J
- Senosiain, M
- Arenas, J
- de la Mata, M
- Turnes, J
- Monge-Romero, MI
- Bustamante-Schneider, J
- Otegui, N
- Molina-Perez, E
- Rodriguez-Menendez, JE
- Varela, M
Grupos
Abstract
Introduction: The appropriate selection of hepatocellular carcinoma (HCC) patients who are eligible for transarterial chemoembolization (TACE) remains a challenge. The ART score has recently been proposed as a method of identifying patients who are eligible or not for a second TACE procedure. Objective: To assess the validity of the Assessment for Retreatment with TACE (ART) score in a cohort of patients treated with drug-eluting bead TACE (DEB-TACE). Secondary objective: to identify clinical determinants associated with overall survival (OS). Method: A retrospective, multicentre study conducted in Spain in patients with HCC having undergone two or more DEB-TACE procedures between January 2009 and December 2014. The clinical characteristics and OS from the day before the second DEB-TACE of patients with a high ART score (ART >= 2.5) and a low ART score (ART 0-1) were compared. Risk factors for mortality were identified using Cox's proportional hazards model. Results: Of the 102 patients included, 51 scored 0-1.5 and 51 scored >= 2.5. Hepatitis C was more frequent in patients scoring >= 2.5. Median OS from the day before the second DEB-TACE was 21 months (95% CI, 15-28) in the group scoring 0-1.5, and 17 months (95% CI, 10-25) in the group scoring >= 2.5 (P=0.3562). Platelet count and tumour size, but not the ART score, were independent baseline predictors of OS. Conclusions: The ART score is not suitable for guiding DEB-TACE retreatment according to Spanish clinical practice standards. (C) 2017 Elsevier Espana, S.L.U., AEEH y AEG. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0210-5705, 0210-5705
- Tipo:
- Article
- Páginas:
- 515-524
- PubMed:
- 28676199
- Factor de Impacto:
- 0,218 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
Gastroenterologia y Hepatologia ELSEVIER ESPANA SLU
Citas Recibidas en Web of Science: 7
Documentos
- No hay documentos
Filiaciones
Keywords
- Hepatocellular; carcinoma; Transarterial liver; chemoembolization; Liver neoplasm; Retrospective study; Survival rate
Portal de investigación